BioSpace News Archive

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has launched a business development program to bring its proprietary MyoPro orthotic product line to a greater number of country markets outside of the United States.

Five abstracts, including one late-breaker, highlighting data from its Cloudbreak® antiviral program have been accepted for presentation at the Options X for the Control of Influenza conference taking place August 28-September 1 in Singapore.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that results from the Phase IIIb FOCUS study, which examined fremanezumab versus placebo in adult migraine patients who previously experienced inadequate responses to two to four classes of preventive treatments, were published online ahead of print in The Lancet.

Launching a franchise can be an exciting, yet daunting adventure. According to data from the U.S. Bureau of Labor Statistics, about 20% of small businesses fail within their first year.

The Primary Ciliary Dyskinesia Foundation (PCDF) has engaged Prometheus Research to deliver the informatics expertise and core technology that will empower the PCDF to accelerate its mission to advance research, diagnosis, care, and ultimately, find a cure for PCD.

One Energy Enterprises, an industrial power company, announced today that it has funded a total of $210,000 in scholarships to local students since the inception of its Megawatt Scholarship program four years ago.

CM-101 was safe and well tolerated using both IV and SC formulations

The global dental diagnostics and surgical equipment market size is poised to grow by USD 3.14 billion during 2019-2023, according to a new report by Technavio, progressing at a CAGR of close to 8% during the forecast period.

Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that S1 Medical, an independent cost containment and medical management firm that provides unique niche programs to the casualty market, has successfully launched Sapiens ClaimsGo for Workers’ Compensation.

Will report financial results for second quarter ended June 30, 2019 on Thursday, August 29, 2019 before the market opens.